Sanara MedTech Inc. (NASDAQ: SMTI) reported Q2 EPS of ($0.22), $0.09 worse than the analyst estimate of ($0.13). Revenue for the quarter came in at $15.75 million versus the consensus estimate of $16.9 million.

For earnings history and earnings-related data on Sanara MedTech Inc. (SMTI) click here.